ATE413399T1 - Morpholinyl-harnstoff-derivative fuer die behandlung von krankheiten verbunden mit entzuendlichen prozessen - Google Patents
Morpholinyl-harnstoff-derivative fuer die behandlung von krankheiten verbunden mit entzuendlichen prozessenInfo
- Publication number
- ATE413399T1 ATE413399T1 AT03745294T AT03745294T ATE413399T1 AT E413399 T1 ATE413399 T1 AT E413399T1 AT 03745294 T AT03745294 T AT 03745294T AT 03745294 T AT03745294 T AT 03745294T AT E413399 T1 ATE413399 T1 AT E413399T1
- Authority
- AT
- Austria
- Prior art keywords
- morpholinyl
- treatment
- diseases associated
- urea derivatives
- inflammatory processes
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000004054 inflammatory process Effects 0.000 title 1
- XMVNCHHPCRFUFT-UHFFFAOYSA-N morpholin-4-ylurea Chemical class NC(=O)NN1CCOCC1 XMVNCHHPCRFUFT-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0207434A GB0207434D0 (en) | 2002-03-28 | 2002-03-28 | Novel compounds |
| GB0301608A GB0301608D0 (en) | 2003-01-24 | 2003-01-24 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE413399T1 true ATE413399T1 (de) | 2008-11-15 |
Family
ID=28676494
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03745294T ATE413399T1 (de) | 2002-03-28 | 2003-03-27 | Morpholinyl-harnstoff-derivative fuer die behandlung von krankheiten verbunden mit entzuendlichen prozessen |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7622464B2 (de) |
| EP (1) | EP1487828B1 (de) |
| JP (1) | JP4465195B2 (de) |
| KR (1) | KR20040093488A (de) |
| CN (1) | CN1656092A (de) |
| AR (1) | AR040403A1 (de) |
| AT (1) | ATE413399T1 (de) |
| AU (1) | AU2003226757A1 (de) |
| BR (1) | BR0308780A (de) |
| CA (1) | CA2480106A1 (de) |
| CY (1) | CY1108652T1 (de) |
| DE (1) | DE60324535D1 (de) |
| DK (1) | DK1487828T3 (de) |
| ES (1) | ES2315519T3 (de) |
| IL (1) | IL164047A0 (de) |
| IS (1) | IS7444A (de) |
| MX (1) | MXPA04009459A (de) |
| NO (1) | NO20044448L (de) |
| PT (1) | PT1487828E (de) |
| RU (1) | RU2004127928A (de) |
| SI (1) | SI1487828T1 (de) |
| TW (1) | TW200400035A (de) |
| WO (1) | WO2003082861A2 (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2511970C (en) | 2003-01-14 | 2012-06-26 | Cytokinetics, Inc. | Urea derivatives useful in the treatment of heart failure |
| EP1608319A4 (de) | 2003-04-03 | 2007-02-28 | Univ California | Verbesserte hemmer für lösliche epoxidhydrolase |
| JP2007532484A (ja) | 2004-03-16 | 2007-11-15 | ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア | 可溶性エポキシド加水分解酵素の阻害剤およびエポキシエイコサノイドを用いて腎症を緩和する方法 |
| BRPI0512193B8 (pt) | 2004-06-17 | 2021-05-25 | Cytokinetics Inc | composto ou sal farmaceuticamente aceitável, composição farmacêutica, e, uso do composto ou sal |
| ES2564167T3 (es) * | 2004-07-08 | 2016-03-18 | Novo Nordisk A/S | Conjugados de polipéptidos de acción prolongada que contienen una fracción tetrazol |
| US7176222B2 (en) | 2004-07-27 | 2007-02-13 | Cytokinetics, Inc. | Syntheses of ureas |
| TW200619212A (en) | 2004-09-08 | 2006-06-16 | Mitsubishi Pharma Corp | Morpholine derivatives |
| EP1814875A4 (de) | 2004-10-20 | 2010-02-17 | Univ California | Verbesserte inhibitoren der löslichen epoxidhydrolase |
| US7538223B2 (en) | 2005-08-04 | 2009-05-26 | Cytokinetics, Inc. | Compounds, compositions and methods |
| US7825120B2 (en) | 2005-12-15 | 2010-11-02 | Cytokinetics, Inc. | Certain substituted ((piperazin-1-ylmethyl)benzyl)ureas |
| ES2419007T3 (es) | 2005-12-15 | 2013-08-19 | Cytokinetics, Inc. | Ciertas entidades químicas, composiciones y procedimientos |
| US7718657B2 (en) | 2005-12-16 | 2010-05-18 | Cytokinetics, Inc. | Certain indanyl urea modulators of the cardiac sarcomere |
| EP1962852B1 (de) | 2005-12-19 | 2017-01-25 | Cytokinetics, Inc. | Verbindungen, zusammensetzungen und verfahren |
| AR059826A1 (es) | 2006-03-13 | 2008-04-30 | Univ California | Inhibidores de urea conformacionalmente restringidos de epoxido hidrolasa soluble |
| ES2663517T3 (es) | 2007-08-27 | 2018-04-13 | Dart Neuroscience (Cayman) Ltd | Compuestos terapéuticos de isoxazol |
| WO2012054093A2 (en) | 2010-01-29 | 2012-04-26 | The Regents Of The University Of California | Acyl piperidine inhibitors of soluble epoxide hydrolase |
| RU2512293C1 (ru) * | 2012-12-13 | 2014-04-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Ярославский государственный технический университет" | Способ получения этил 1,2,4-оксадиазол-5-карбоксилатов |
| CN107362362B (zh) * | 2017-07-20 | 2019-01-01 | 复旦大学 | Sirt1抑制剂在预防和治疗放射引起的肠道疾病中的应用 |
| US20230271983A1 (en) * | 2020-07-29 | 2023-08-31 | Universidade De Santiago De Compostela | Functionalized isonitriles and products, preparation and uses thereof |
| WO2022031735A1 (en) * | 2020-08-03 | 2022-02-10 | Global Blood Therapeutics, Inc. | Urea derivatives as pyruvate kinase activators |
| CN119330881A (zh) * | 2024-09-06 | 2025-01-21 | 苏州汉德创宏生化科技有限公司 | 一种3-氨甲基-1-h吡唑的合成方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4851526A (en) | 1987-09-04 | 1989-07-25 | Schering A.G. | 1-(4-Substituted phenyl)-1H-imidazoles compounds |
| JP3087763B2 (ja) * | 1990-11-30 | 2000-09-11 | 三井化学株式会社 | 新規な複素環式化合物およびそれを含有する医薬組成物 |
| US5219856A (en) * | 1992-04-06 | 1993-06-15 | E. I. Du Pont De Nemours And Company | Angiotensin-II receptor blocking, heterocycle substituted imidazoles |
| EP0759918A1 (de) | 1994-05-19 | 1997-03-05 | MERCK SHARP & DOHME LTD. | Indol-3-ylalkyl-piperidin-piperazin, -piperidin und tetrahydropyridin-derivate als 5-ht1 d-alpha agonisten |
| AU702307B2 (en) | 1994-07-20 | 1999-02-18 | Altana Pharma Ag | Piperazinothiopyridines for the control of helicobater bacteria |
| US5654316A (en) | 1995-06-06 | 1997-08-05 | Schering Corporation | Piperidine derivatives as neurokinin antagonists |
| AU2980797A (en) | 1996-06-11 | 1998-01-07 | Yoshitomi Pharmaceutical Industries, Ltd. | Fused heterocyclic compounds and medicinal uses thereof |
| US5919776A (en) * | 1996-12-20 | 1999-07-06 | Merck & Co., Inc. | Substituted aminoquinolines as modulators of chemokine receptor activity |
| US6207665B1 (en) | 1997-06-12 | 2001-03-27 | Schering Aktiengesellschaft | Piperazine derivatives and their use as anti-inflammatory agents |
| IT1293807B1 (it) | 1997-08-01 | 1999-03-10 | Recordati Chem Pharm | Derivati 1- (n-fenilaminoalchil) piperazinici sostituiti alla posizione 2 dell'anello fenilico |
| AU1122399A (en) | 1997-10-27 | 1999-05-17 | Neurogen Corporation | Novel 1-(n'-(arylalkylaminoalkyl))aminoisoindoles; a new class of dopamine receptor subtype specific ligands |
| US6031097A (en) * | 1997-10-27 | 2000-02-29 | Neurogen Corporation | 1-(N-(arylalkylaminoalkyl) aminoisoquinolines; a new class of dopamine receptor subtype specific ligands |
| WO2000018767A2 (en) | 1998-09-30 | 2000-04-06 | Neurogen Corporation | 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands |
| CZ20031194A3 (cs) | 2000-09-29 | 2003-08-13 | Glaxo Group Limited | Deriváty močoviny |
| IL155093A0 (en) | 2000-09-29 | 2003-10-31 | Glaxo Group Ltd | Morpholin-acetamide derivatives for the treatment on inflammatory diseases |
-
2003
- 2003-03-26 TW TW092106766A patent/TW200400035A/zh unknown
- 2003-03-27 AU AU2003226757A patent/AU2003226757A1/en not_active Abandoned
- 2003-03-27 JP JP2003580326A patent/JP4465195B2/ja not_active Expired - Lifetime
- 2003-03-27 IL IL16404703A patent/IL164047A0/xx unknown
- 2003-03-27 US US10/509,162 patent/US7622464B2/en not_active Expired - Lifetime
- 2003-03-27 AR AR20030101081A patent/AR040403A1/es unknown
- 2003-03-27 AT AT03745294T patent/ATE413399T1/de active
- 2003-03-27 DK DK03745294T patent/DK1487828T3/da active
- 2003-03-27 SI SI200331471T patent/SI1487828T1/sl unknown
- 2003-03-27 PT PT03745294T patent/PT1487828E/pt unknown
- 2003-03-27 BR BR0308780-8A patent/BR0308780A/pt not_active Application Discontinuation
- 2003-03-27 CN CNA038115506A patent/CN1656092A/zh active Pending
- 2003-03-27 MX MXPA04009459A patent/MXPA04009459A/es unknown
- 2003-03-27 KR KR10-2004-7015398A patent/KR20040093488A/ko not_active Withdrawn
- 2003-03-27 ES ES03745294T patent/ES2315519T3/es not_active Expired - Lifetime
- 2003-03-27 WO PCT/EP2003/003335 patent/WO2003082861A2/en not_active Ceased
- 2003-03-27 DE DE60324535T patent/DE60324535D1/de not_active Expired - Lifetime
- 2003-03-27 RU RU2004127928/04A patent/RU2004127928A/ru not_active Application Discontinuation
- 2003-03-27 EP EP03745294A patent/EP1487828B1/de not_active Expired - Lifetime
- 2003-03-27 CA CA002480106A patent/CA2480106A1/en not_active Abandoned
-
2004
- 2004-09-13 IS IS7444A patent/IS7444A/is unknown
- 2004-10-19 NO NO20044448A patent/NO20044448L/no not_active Application Discontinuation
-
2008
- 2008-12-19 CY CY20081101474T patent/CY1108652T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2315519T3 (es) | 2009-04-01 |
| MXPA04009459A (es) | 2005-01-25 |
| CA2480106A1 (en) | 2003-10-09 |
| CY1108652T1 (el) | 2014-08-13 |
| DK1487828T3 (da) | 2009-02-02 |
| AU2003226757A1 (en) | 2003-10-13 |
| WO2003082861A2 (en) | 2003-10-09 |
| JP4465195B2 (ja) | 2010-05-19 |
| NO20044448L (no) | 2004-10-26 |
| BR0308780A (pt) | 2004-12-28 |
| KR20040093488A (ko) | 2004-11-05 |
| IL164047A0 (en) | 2005-12-18 |
| US7622464B2 (en) | 2009-11-24 |
| SI1487828T1 (sl) | 2009-04-30 |
| RU2004127928A (ru) | 2005-06-27 |
| JP2005526815A (ja) | 2005-09-08 |
| WO2003082861A3 (en) | 2004-03-11 |
| DE60324535D1 (de) | 2008-12-18 |
| CN1656092A (zh) | 2005-08-17 |
| PT1487828E (pt) | 2009-01-06 |
| AR040403A1 (es) | 2005-04-06 |
| IS7444A (is) | 2004-09-13 |
| EP1487828B1 (de) | 2008-11-05 |
| EP1487828A2 (de) | 2004-12-22 |
| TW200400035A (en) | 2004-01-01 |
| US20060063765A1 (en) | 2006-03-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60324535D1 (de) | Morpholinyl-harnstoff-derivative fuer die behandlung von krankheiten verbunden mit entzuendlichen prozessen | |
| ATE374196T1 (de) | Dihydrobenzodiazepin-2-on-derivative für die behandlung von neurologischen erkrankungen | |
| DE60329123D1 (de) | Benzoädüazepinderivate für die behandlung von neurologischen krankheiten | |
| ATE418554T1 (de) | 1-acyl-pyrrolidin-derivate für die behandlung von viralen infektionen | |
| ATE417037T1 (de) | Diarylharnstoffderivate, die sich zur behandlung von proteinkinaseabhängigen krankheiten eignen | |
| NL1026329A1 (nl) | 2-Amino-pyridinederivaten toepasbaar voor de behandeling van ziekten. | |
| ATE512163T1 (de) | Verabreichung von mitteln zur behandlung von entzündungen | |
| NL1025071A1 (nl) | Verbindingen voor de behandeling van abnormale celgroei. | |
| DE602005023172D1 (de) | Hydantoinderivate zur behandlung von entzündlichen erkrankungen | |
| DE60218493D1 (de) | Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten | |
| NO20053077D0 (no) | Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer. | |
| DE60108754D1 (de) | Substituierte bizyklische derivate für die behandlung von unnormalem zellwachstum | |
| ATE345331T1 (de) | Verbindungen verwendbar für die behandlung von entzündungskrankheiten | |
| DE60233414D1 (de) | Kombinationen für die behandlung entzündlicher erkrankungen | |
| NL1026327A1 (nl) | 2-Amino-pyridinederivaten toepasbaar voor de behandeling van ziekten. | |
| NO20052894D0 (no) | 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte | |
| NO20041882L (no) | Fremgangsmater for behandling av okulare neovaskulaere sykdommer. | |
| DE602005005810D1 (de) | Verwendung von substituierten chinolin-derivaten zur behandlung von arzneimittelresistenten mycobakteriellen erkrankungen | |
| ATE540949T1 (de) | Substituierte pteridine zur behandlung von entzündlichen erkrankungen | |
| ATE502642T1 (de) | Kombinationen für die behandlung von immun- entzündlichen erkrankungen | |
| ATE424386T1 (de) | Pyridin-verbindungen für die behandlung von prostaglandin-vermittelten krankheiten | |
| NL1026203A1 (nl) | Verbindingen toepasbaar voor de behandeling van ziekten. | |
| ATE443704T1 (de) | Pyridopyrimidinone zur behandlung von krebserkrankungen | |
| IL163951A (en) | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them | |
| DE60206289D1 (de) | Verwendung von bibn4096 in kombination mit anderen migränemitteln zur behandlung von migräne |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1487828 Country of ref document: EP |